Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

WARGO, JENNIFER

One or more keywords matched the following items that are connected to WARGO, JENNIFER

Item Type	Name
Concept	MAP Kinase Signaling System
Concept	Mitogen-Activated Protein Kinase 1
Concept	Mitogen-Activated Protein Kinase Kinases
Concept	MAP Kinase Kinase Kinases
Concept	Mitogen-Activated Protein Kinase 3
Concept	MAP Kinase Kinase 1
Academic Article	Systematic identification of signaling pathways with potential to confer anticancer drug resistance.
Academic Article	RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E).
Academic Article	BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma.
Academic Article	Potential role of 5-aza-2'-deoxycytidine induced MAGE-A4 expression in immunotherapy for anaplastic thyroid cancer.
Academic Article	MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibition.
Academic Article	COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.
Academic Article	Case records of the Massachusetts General Hospital. Case 21-2013. A 68-year-old man with metastatic melanoma.
Academic Article	A melanocyte lineage program confers resistance to MAP kinase pathway inhibition.
Academic Article	Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function.
Academic Article	EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib.
Academic Article	The activation of MAPK in melanoma cells resistant to BRAF inhibition promotes PD-L1 expression that is reversible by MEK and PI3K inhibition.
Academic Article	Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma.
Academic Article	TORC1 suppression predicts responsiveness to RAF and MEK inhibition in BRAF-mutant melanoma.
Academic Article	PDGFRa up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation.
Academic Article	A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors.
Academic Article	The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFa.
Academic Article	Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1a and oxidative phosphorylation in melanoma.
Academic Article	The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies.
Academic Article	YAP in MAPK pathway targeted therapy resistance.
Academic Article	Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial.
Academic Article	Interaction of molecular alterations with immune response in melanoma.
Academic Article	An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition.
Academic Article	Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma.
Academic Article	Genetic and Genomic Characterization of 462 Melanoma Patient-Derived Xenografts, Tumor Biopsies, and Cell Lines.
Academic Article	Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in Braf-mutated melanoma.
Academic Article	Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
Academic Article	Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma.

Search Criteria

Mitogen Activated Protein Kinase 1